Table 1.

Effects of SCH23390, sulpiride, naltrexone, and GYKI 52466 on food-induced conditioned activity (means ± SEM) measured during run A and run B (20 min)

Pharmacological treatmentDose (mg/kg)Forward activity during run AForward activity during run B
GroupGroup
FHFRFHFR
SCH23390037.8 ± 12.1351.67 ± 13.4576.50 ± 18.85124.11 ± 35.83
0.01542.50 ± 7.8558.89 ± 17.2858.10 ± 20.26125.89 ± 45.35
0.0365.33 ± 19.8451.10 ± 12.2010.00 ± 3.8588.44 ± 40.69
Sulpiride093.43 ± 20.35168.22 ± 30.6362.00 ± 12.83199.44 ± 37.22
2592.14 ± 28.65148.22 ± 25.5560.14 ± 15.59210.67 ± 47.23
7540.86 ± 12.94110.22 ± 25.7040.29 ± 15.27138.22 ± 24.98
12536.29 ± 7.3368.89 ± 11.4232.43 ± 12.42125.33 ± 24.95
Naltrexone067.50 ± 22.97102.12 ± 23.4030.30 ± 12.44145.00 ± 52.11
1044.80 ± 9.1359.25 ± 13.7436.20 ± 9.01107.12 ± 39.41
2021.80 ± 9.1940.50 ± 14.0432.30 ± 12.5859.25 ± 15.94
GYKI 52466033.60 ± 6.8086.78 ± 31.9445.70 ± 18.33167.55 ± 68.06
553.90 ± 6.3479.56 ± 29.6128.10 ± 10.89134.89 ± 47.13
1041.30 ± 6.3437.44 ± 8.887.00 ± 3.267.22 ± 2.36